Welcome to our dedicated page for Celsius Holdings SEC filings (Ticker: CELH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Celsius Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Celsius Holdings's regulatory disclosures and financial reporting.
Dean DeSantis, as trustee, reported a variable prepaid forward transaction affecting 7,900,000 shares of Celsius Holdings, Inc. (CELH). CD Financial, LLC entered into the contract with Citigroup Global Markets Inc. on August 7, 2025, obligating CD to potentially deliver up to 7,900,000 shares in approximately 15 equal components maturing from September 7, 2027 to September 27, 2027. In exchange CD will receive $372,347,277.72 on September 9, 2025. The pledged shares secure the obligation while CD retains dividend and voting rights during the pledge. Settlement mechanics depend on a Floor Price of $48.4239 and a Cap Price of $64.5652, with formulas specified for share delivery or net/ cash settlement options.
Paul H. Storey, Chief Supply Chain Officer of Celsius Holdings, Inc. (CELH), reported the sale of 7,500 shares of the company's common stock on 09/03/2025 at a weighted-average price of $60.93 per share. After the sale he beneficially owns 37,550 shares outright and an additional 450 shares held indirectly by his spouse. The Form 4 was signed by an attorney-in-fact on 09/05/2025. The filing notes the sale occurred in multiple transactions with prices ranging from $60.93 to $60.95.
Celsius Holdings (CELH) filed a Form 144 indicating a proposed sale of 7,500 common shares through Fidelity Brokerage Services with an aggregate market value of $456,981.72. The filing shows the shares equal the sum of restricted stock vesting awards received as compensation on 01/08/2024 (698 shares), 01/01/2025 (2,305 shares), 03/01/2025 (1,377 shares) and 05/05/2025 (3,120 shares), totaling 7,500 shares. The filer reports no securities sold in the past three months. The proposed approximate sale date is 09/03/2025, and the filing includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Celsius Holdings, Inc. entered into a series of transactions with PepsiCo, Inc. under which PepsiCo previously purchased 1,466,666 shares of Series A Convertible Preferred Stock and, on the Closing Date, purchased 390,000 shares of newly created Series B Convertible Preferred Stock for an aggregate purchase price of $585.0 million in cash. Each share of Series B is initially convertible into 11,304,348 shares of common stock (on an as-converted basis). The parties amended and restated the registration rights agreement to include the common stock issuable on conversion of Series B and preserved customary demand, resale and piggyback registration rights for PepsiCo. PepsiCo became the Company’s exclusive U.S. distributor for certain beverage products in the defined territory under an amended distribution agreement, and a channel transition agreement covers transfer of certain existing Alani Nu distribution rights and related financial commitments. The Board was increased from nine to ten members and Michael Del Pozzo was appointed as a PepsiCo designee; board designation rights for PepsiCo are subject to ownership thresholds. Several definitive agreements and certificates were executed and filed as exhibits.
Jarrod Langhans, Chief Financial Officer of Celsius Holdings, Inc. (CELH), reported an insider sale. On 08/18/2025 he disposed of 5,000 shares of CELH common stock at $60.00 per share, leaving him with 104,227 shares beneficially owned after the transaction. The filing indicates the sale was effected under a Rule 10b5-1 trading plan that the reporting person adopted on September 13, 2024. The Form 4 was signed by an attorney-in-fact on 08/19/2025. No derivative transactions or additional material details are disclosed in this filing.
Form 144 filed for Celsius Holdings, Inc. (CELH) reports a proposed sale of 5,000 common shares to be executed through UBS Financial Services on Nasdaq with an aggregate market value of $300,000. The filing shows the issuer has 257,946,135 shares outstanding.
The shares being sold were originally acquired as RSU grants: 4,450 shares on 04/18/2022 and 550 shares on 08/19/2022. The filing also discloses a prior sale of 5,000 common shares on 08/07/2025 that generated $255,900 in gross proceeds. The filer certifies they are not aware of undisclosed material adverse information.
Jarrod Langhans, Chief Financial Officer of Celsius Holdings, Inc. (CELH) reported the sale of 5,000 shares of the issuer's common stock on 08/07/2025 at a reported price of $51.18 per share. After this transaction the filing shows the reporting person beneficially owns 109,227 shares.
The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024. No derivative transactions are reported in the filing and no other changes to ownership or company operations are disclosed in the document.
John Fieldly, who is both Chief Executive Officer and a director of Celsius Holdings, Inc. (CELH), reported a sale of 143,167 shares of the company's common stock on 08/07/2025 at a reported price of $51.18 per share. After the reported transaction, the filing shows he directly beneficially owned 895,410 shares.
The Form 4 indicates the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2025. The form was filed by one reporting person and signed by an attorney-in-fact on 08/08/2025.
Celsius Holdings reported sizeable growth in the first half of 2025 driven by its April 1, 2025 acquisition of Alani Nu and strong North American sales. Revenue rose to $739.3 million for the quarter (from $402.0 million prior-year) and $1.07 billion for six months (from $757.7 million). Quarterly net income was $99.9 million, with net income attributable to common stockholders of $85.7 million and basic EPS of $0.33. Gross profit expanded to $380.9 million.
The balance sheet reflects the Acquisition: total assets increased to $3.795 billion from $1.767 billion, goodwill rose to $802.2 million, and indefinite-lived brands were recognized at $1.104 billion. The company drew a $900 million term loan (long-term debt net of discounts $862.9 million) to partially fund the acquisition and used cash on hand, reducing cash to $615.2 million. Promotional allowances and concentrations with a major distributor (Pepsi) remain material. Pro forma metrics show higher combined revenue and net income when Alani Nu is included for prior periods.
Celsius Holdings (CELH) filed a Form 144 notice covering the proposed sale of 7,900,000 common shares, equal to roughly 3.1 % of the 257.7 million shares outstanding. Based on the filing’s reference price, the block is valued at $404.3 million. Sales are expected to begin on or about 7 Aug 2025 through Citigroup Global Markets on Nasdaq.
The stock originated from two prior conversions: (1) 3.0 million shares issued on 12 Dec 2018 when a convertible note was exchanged, fully paid 19 Sep 2019, and (2) 2.103 million shares issued on 16 Apr 2015 from Series A preferred conversion. In the past three months the filing party, identified as CD Financial LLC, already sold 1.692 million shares for $77.8 million in gross proceeds.
Form 144 is only a notice and does not obligate execution, yet a sale of this magnitude by an early investor could create short-term supply pressure and be interpreted as profit-taking. No operational or earnings data accompanied the filing.